Israel Englander Iterum Therapeutics PLC Transaction History

Millennium Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.19 - $0.36 $16,739 - $31,716	88,101 New	88,101 $18,000
Q4 2021 Feb 14, 2022	SELL	$0.39 - $0.74 $50,969 - $96,711	-130,691 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$0.54 - $2.29 $1.31 Million - $5.56 Million	-2,429,690 Reduced 94.9%	130,691 $73,000
Q2 2021 Aug 16, 2021	BUY	$0.97 - $2.39 $2.41 Million - $5.94 Million	2,485,175 Added 3304.49%	2,560,381 $5.91 Million
Q1 2021 May 17, 2021	BUY	$0.97 - $2.73 $72,949 - $205,312	75,206 New	75,206 $106,000
Q4 2019 Feb 14, 2020	SELL	$1.7 - $5.99 $43,744 - $154,134	-25,732 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$5.77 - $7.65 $19,687 - $26,101	-3,412 Reduced 11.71%	25,732 $151,000
Q2 2019 Aug 15, 2019	SELL	$6.09 - $9.1 $17,825 - $26,635	-2,927 Reduced 9.13%	29,144 $201,000
Q1 2019 May 14, 2019	SELL	$4.88 - $8.17 $11,712 - $19,608	-2,400 Reduced 6.96%	32,071 $258,000
Q4 2018 Feb 14, 2019	SELL	$5.01 - $7.9 $80,350 - $126,700	-16,038 Reduced 31.75%	34,471 $173,000
Q3 2018 Nov 14, 2018	SELL	$6.24 - $10.4 $754,752 - $1.26 Million	-120,954 Reduced 70.54%	50,509 $338,000
Q2 2018 Aug 14, 2018	BUY	$10.67 - $12.85 $1.83 Million - $2.2 Million	171,463 New	171,463 $1.87 Million

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $15.9M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.